Poniard (PARD) Puts Annual Meeting on Hold to Gain Support for Important Stock Split Proposal
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), intends to adjourn its annual meeting of shareholders scheduled for Friday, July 8, 2011, until Friday, July 22, 2011, in order to solicit additional proxies to vote in favor of a proposal authorizing the Company's Board of Directors, in its discretion, to effect a reverse stock split in the range of 1-for-15 to 1-for-25.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Galena Biopharma (GALE) Receives FDA Warning Letter Over Abstral Tablet Manufacturing
- BlackBerry (BBRY) Acquires WatchDox
- Telus (TU) Plans $2.1B Investment in Ontario Through 2018
Create E-mail Alert Related CategoriesCorporate News, Stock Splits
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!